tiprankstipranks
United Therapeutics management to meet with Oppenheimer
PremiumThe FlyUnited Therapeutics management to meet with Oppenheimer
1M ago
Hunterbrook goes long Liquidia into trial over lung disease treatment
Premium
The Fly
Hunterbrook goes long Liquidia into trial over lung disease treatment
1M ago
Y-mAbs Therapeutics initiated with a Buy at Brookline on Danyelza potential
Premium
The Fly
Y-mAbs Therapeutics initiated with a Buy at Brookline on Danyelza potential
1M ago
United Therapeutics Reports Strong Q3 2024 Results
PremiumCompany AnnouncementsUnited Therapeutics Reports Strong Q3 2024 Results
3M ago
United Therapeutics reports Q3 EPS $6.93, consensus $6.42
Premium
The Fly
United Therapeutics reports Q3 EPS $6.93, consensus $6.42
3M ago
UTHR Earnings this Week: How Will it Perform?
Premium
Pre-Earnings
UTHR Earnings this Week: How Will it Perform?
3M ago
Liquidia says court finds United’s interference caused losses over $137M
PremiumThe FlyLiquidia says court finds United’s interference caused losses over $137M
4M ago
MannKind assumed with an Outperform at Leerink
Premium
The Fly
MannKind assumed with an Outperform at Leerink
4M ago
MannKind price target raised to $12 from $10 at Oppenheimer
Premium
The Fly
MannKind price target raised to $12 from $10 at Oppenheimer
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100